Literature DB >> 23643110

A structural multidisciplinary approach to depression management in nursing-home residents: a multicentre, stepped-wedge cluster-randomised trial.

Ruslan Leontjevas1, Debby L Gerritsen, Martin Smalbrugge, Steven Teerenstra, Myrra J F J Vernooij-Dassen, Raymond T C M Koopmans.   

Abstract

BACKGROUND: Depression in nursing-home residents is often under-recognised. We aimed to establish the effectiveness of a structural approach to its management.
METHODS: Between May 15, 2009, and April 30, 2011, we undertook a multicentre, stepped-wedge cluster-randomised trial in four provinces of the Netherlands. A network of nursing homes was invited to enrol one dementia and one somatic unit per nursing home. In enrolled units, nursing-home staff recruited residents, who were eligible as long as we had received written informed consent. Units were randomly allocated to one of five groups with computer-generated random numbers. A multidisciplinary care programme, Act in Case of Depression (AiD), was implemented at different timepoints in each group: at baseline, no groups were implenting the programme (usual care); the first group implemented it shortly after baseline; and other groups sequentially began implementation after assessments at intervals of roughly 4 months. Residents did not know when the intervention was being implemented or what the programme elements were; research staff were masked to intervention implementation, depression treatment, and results of previous assessments; and data analysts were masked to intervention implementation. The primary endpoint was depression prevalence in units, which was the proportion of residents per unit with a score of more than seven on the proxy-based Cornell scale for depression in dementia. Analyses were by intention to treat. This trial is registered with the Netherlands National Trial Register, number NTR1477.
FINDINGS: 16 dementia units (403 residents) and 17 somatic units (390 residents) were enrolled in the course of the study. In somatic units, AiD reduced prevalence of depression (adjusted effect size -7·3%, 95% CI -13·7 to -0·9). The effect was not significant in dementia units (0·6, -5·6 to 6·8) and differed significantly from that in somatic units (p=0·031). Adherence to depression assessment procedures was lower in dementia units (69% [SD 19%]) than in somatic units (82% [15%]; p=0·045). Adherence to treatment pathways did not differ between dementia units (43% [SD 33%]) and somatic units (38% [40%]; p=0·745).
INTERPRETATION: A structural approach to management of depression in nursing homes that includes assessment procedures can reduce depression prevalence in somatic units. Improvements are needed in depression screening in dementia units and in implementation of nursing-home treatment protocols generally. FUNDING: The Netherlands Organization for Health Research and Development.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23643110     DOI: 10.1016/S0140-6736(13)60590-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Authors:  Eric J Lenze; Benoit H Mulsant; Daniel M Blumberger; Jordan F Karp; John W Newcomer; Stewart J Anderson; Mary Amanda Dew; Meryl A Butters; Jacqueline A Stack; Amy E Begley; Charles F Reynolds
Journal:  Lancet       Date:  2015-09-27       Impact factor: 79.321

2.  Comparison of statistical models for estimating intervention effects based on time-to-recurrent-event in stepped wedge cluster randomized trial using open cohort design.

Authors:  Shunsuke Oyamada; Shih-Wei Chiu; Takuhiro Yamaguchi
Journal:  BMC Med Res Methodol       Date:  2022-04-26       Impact factor: 4.612

Review 3.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Phuong Leung; Rafael Del-Pino-Casado; Afifa Qazi; Martin Orrell; Aimee E Spector; Abigail M Methley
Journal:  Cochrane Database Syst Rev       Date:  2022-04-25

Review 4.  Late-life depression: issues for the general practitioner.

Authors:  Axel Van Damme; Tom Declercq; Lieve Lemey; Hannelore Tandt; Mirko Petrovic
Journal:  Int J Gen Med       Date:  2018-03-29

5.  Targeted case finding in the prevention of cardiovascular disease: a stepped wedge cluster randomised controlled trial.

Authors:  Karla Hemming; Ronan Ryan; Paramjit Gill; Paul Westerby; Kate Jolly; Tom Marshall
Journal:  Br J Gen Pract       Date:  2016-08-15       Impact factor: 5.386

6.  A multifaceted workplace intervention for low back pain in nurses' aides: a pragmatic stepped wedge cluster randomised controlled trial.

Authors:  Charlotte Diana Nørregaard Rasmussen; Andreas Holtermann; Hans Bay; Karen Søgaard; Marie Birk Jørgensen
Journal:  Pain       Date:  2015-09       Impact factor: 7.926

7.  Process evaluation of the implementation of dementia-specific case conferences in nursing homes (FallDem): study protocol for a randomized controlled trial.

Authors:  Daniela Holle; Martina Roes; Ines Buscher; Sven Reuther; René Müller; Margareta Halek
Journal:  Trials       Date:  2014-12-11       Impact factor: 2.279

Review 8.  Stepped wedge cluster randomised trials: a review of the statistical methodology used and available.

Authors:  D Barker; P McElduff; C D'Este; M J Campbell
Journal:  BMC Med Res Methodol       Date:  2016-06-06       Impact factor: 4.615

Review 9.  A Systematic Review of Interventions to Change Staff Care Practices in Order to Improve Resident Outcomes in Nursing Homes.

Authors:  Lee-Fay Low; Jennifer Fletcher; Belinda Goodenough; Yun-Hee Jeon; Christopher Etherton-Beer; Margaret MacAndrew; Elizabeth Beattie
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

10.  Statistical efficiency and optimal design for stepped cluster studies under linear mixed effects models.

Authors:  Alan J Girling; Karla Hemming
Journal:  Stat Med       Date:  2016-01-07       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.